Chengdu Olymvax Biopharmaceuticals Inc.
Status: Publicly traded
Direct answer
Chengdu Olymvax Biopharmaceuticals Inc. is publicly traded on SHH under the ticker 688319.SS.
Chengdu Olymvax Biopharmaceuticals Inc. specializes in the research, development, and distribution of vaccines. Their current product portfolio includes immunizations against tetanus, a severe and often fatal infectious disease that damages the nervous system due to toxins produced by Clostridium tetani, alongside a vaccine for Haemophilus influenzae type b. Beyond their existing offerings, the company is actively...
Can you invest in Chengdu Olymvax Biopharmaceuticals Inc.?
Yes. Chengdu Olymvax Biopharmaceuticals Inc. is publicly traded on SHH under the ticker 688319.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Chengdu Olymvax Biopharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.